Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; 16 of the 54 sources its claims cite were checked for support.
Abstract
Euglycemic hyperinsulinemia evokes both sympathetic activation and vasodilation in skeletal muscle, but the mechanism remains unknown. To determine whether insulin per se or insulin-induced stimulation of carbohydrate metabolism is the main excitatory stimulus, we performed, in six healthy lean subjects, simultaneous microneurographic recordings of muscle sympathetic nerve activity, plethysmographic measurements of calf blood flow, and calorimetric determinations of carbohydrate oxidation rate. Measurements were made during 2 h of: (a) insulin/glucose infusion (hyperinsulinemic [6 pmol/kg per min] euglycemic clamp), (b) exogenous glucose infusion at a rate matched to that attained during protocol a, and (c) exogenous fructose infusion at the same rate as for glucose infusion in protocol b. For a comparable rise in carbohydrate oxidation, insulin/glucose infusion that resulted in twofold greater increases in plasma insulin concentrations than did glucose infusion alone, evoked twofold greater increases in both muscle sympathetic nerve activity and calf blood flow. Fructose infusion, which increased carbohydrate oxidation comparably, but had only a minor effect on insulinemia, did not stimulate either muscle sympathetic nerve activity or calf blood flow. These observations suggest that in humans hyperinsulinemia per se, rather than insulin-induced stimulation of carbohydrate metabolism, is the main mechanism that triggers both sympathetic activation and vasodilation in skeletal muscle.
Overview
CoChat Summary
TL;DR
In healthy lean humans, euglycemic hyperinsulinemia increased muscle sympathetic nerve activity (MSNA) and calf blood flow more than glucose infusion alone despite comparable carbohydrate oxidation, while fructose infusion increased carbohydrate oxidation without stimulating MSNA or calf blood flow. The authors conclude that hyperinsulinemia per se, rather than insulin-induced carbohydrate metabolism, is the main trigger for sympathetic activation and skeletal-muscle vasodilation.
Key findings
- During 2-h insulin/glucose infusion, plasma insulin rose to 376.2±30.0 pmol/liter and increased MSNA burst frequency by 93±18%, calf blood flow by 47±14%, and decreased calf vascular resistance by 19±4%.
- Glucose infusion alone produced comparable carbohydrate oxidation but a smaller insulin rise (282.6±19.8 pmol/liter) and about half the responses: MSNA burst frequency increased 54±10% and calf blood flow 20±6%.
- Fructose infusion increased carbohydrate oxidation even more than insulin/glucose or glucose infusion (23±2 vs 21±1 and 20±1 μmol/kg per min at 90–120 min) but caused only a minor insulin rise (37.2±1.9 to 57.0±2.7 pmol/liter) and had no effect on MSNA, calf blood flow, or calf vascular resistance.
- MSNA and calf blood flow rose significantly at 45 min during insulin/glucose infusion but only at 90 min during glucose infusion; during fructose infusion, glucose oxidation increased by 22±7%.
Methods
- Six lean, healthy subjects (weight 70.8±4.3 kg, BMI 21.8±0.8 kg/m², age 28±4 yr) underwent 2-h protocols: hyperinsulinemic euglycemic clamp (insulin 6 pmol/kg per min), exogenous glucose infusion matched to the clamp, and fructose infusion matched to glucose; five of six subjects completed fructose infusion.
- Simultaneous measurements included microneurographic MSNA recordings from the peroneal nerve, venous occlusion plethysmography for calf blood flow, indirect calorimetry for carbohydrate oxidation, and plasma hormone/substrate assays.
- A fourth protocol in six lean healthy male subjects (age 30±4 yr, BMI 22.9±0.6 kg/m²) used [U-¹³C]glucose infusion and breath ¹³CO₂/plasma [¹³C]glucose enrichment to measure glucose oxidation during fructose infusion.
- Statistical analysis used repeated-measures ANOVA, paired t tests with Bonferroni adjustment, and least-squares correlations; P<0.05 was significant.
Limitations
- The paper states that indirect calorimetry cannot differentiate glucose from fructose oxidation, that nonoxidative glucose disposal calculations were not performed during fructose infusion because endogenous glucose production was not measured and is not suppressed, and that total carbohydrate uptake may have been slightly higher during fructose infusion.
- The paper states that the experiments do not elucidate the underlying mechanisms of insulin-induced sympathetic activation and vasodilation, and that MSNA recordings were targeted specifically at skeletal muscle, so fructose-induced sympathetic outflow to other tissues such as liver cannot be excluded.
- Evident from the text: the main protocols included only six lean healthy subjects (five for fructose), limiting generalizability; the fourth protocol included only male subjects, and the study did not measure interstitial insulin directly.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 0 Not valid · 16 Not checked · 51 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“First, there is increasing evidence that stimulation of blood flow to insulin-sensitive tissues during insulin/glucose and glucose infusion may be an important determinant of the rate of in vivo glucose uptake (10, 11, 38).”
What the sources say
- Not matchedcites [10] 10. Laakso, M., S. V. Edelman, J. M. Olefsky, G. Brechtel, P. Wallace, and A. D. Baron. 1990. Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes. 39:965-974.
More than one paper fits this citation.
- Partly supportedcites [11] 11. Laakso, M., S. V. Edelman, G. Brechtel, and A. D. Baron. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J. Clin. Invest. 85:1844–1852. sourceExperimental — accuracy not yet measured
The Discussion (page not provided) says increased blood flow is closely linked to glucose uptake and may contribute particularly after two hours of hyperinsulinemia. The Protocol describes insulin infusion with glucose clamped at euglycemia, but the paper does not establish the same point for glucose infusion without insulin. Its findings also concern skeletal muscle rather than insulin-sensitive tissues generally. (LLM, conf=0.85)
- Not matchedcites [38] 38. Edelman, S. V., M. Laakso, P. Wallace, G. Brechtel, J. M. Olefsky, and A. D. Baron. 1990. Kinetics of insulin-mediated and non-insulin-mediated glucose uptake in humans. Diabetes. 39:955–964.
More than one paper fits this citation.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“as recent evidence indicates that insulin resistance is associated with attenuated hyperinsulinemia-induced vasodilation in skeletal muscle (10, 11).”
What the sources say
- Not matchedcites [10] 10. Laakso, M., S. V. Edelman, J. M. Olefsky, G. Brechtel, P. Wallace, and A. D. Baron. 1990. Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes. 39:965-974.
More than one paper fits this citation.
- Supportedcites [11] 11. Laakso, M., S. V. Edelman, G. Brechtel, and A. D. Baron. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J. Clin. Invest. 85:1844–1852. source
The Discussion reports that insulin’s effect on skeletal-muscle blood flow is impaired in obese men and that this defect could be associated with in vivo insulin resistance. Its summary also describes a right-shifted blood-flow response to insulin in obese versus lean subjects. The finding is established for the men studied; extension to other insulin-resistant states is presented as a possibility. (LLM, conf=0.91)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, the conclusions of one study were based upon the absence of a detectable effect of glucose infusion on plasma norepinephrine levels (5, 26), a relatively insensitive index of sympathetic discharge (34–36).”
What the sources say
- Partly supportedcites [5] 5. Berne, C., J. Fagius, and F. Niklasson. 1989. Sympathetic response to oral carbohydrate administration. J. Clin. Invest. 84:1403-1409. sourceExperimental — accuracy not yet measured
The Sympathetic activity results report minor or no plasma norepinephrine change after intravenous glucose. But the Discussion bases its conclusion that intravenous glucose did not increase sympathetic activity on direct microelectrode recordings of muscle sympathetic activity, using the norepinephrine results as corroboration—not as the sole basis for the conclusion. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [26] 26. Rowe, J. W., J. B. Young. K. L. Minaker, A. L. Stevens, J. Pallota, and L. Landsberg. 1981. Effects of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:219–225. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Second, a balance between insulin's opposing sympathoexcitatory pressor and vasodilatory depressor effects may offer a potential explanation for the present, and earlier (6, 7, 26) observations, that in lean healthy subjects acute hyperinsulinemia at high physiologic concentrations does not raise arterial pressure.”
What the sources say
- Partly supportedcites [6] 6. Anderson, E. A., R. P. Hoffman, T. W. Balon, C. A. Sinkey, and A. L. Mark. 1991. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87:2246–2252. sourceExperimental — accuracy not yet measured
The Discussion says that sympathetic pressor and vasodilatory depressor actions appear relatively balanced during acute insulin increases in the physiologic postprandial range, so arterial pressure does not rise. The Subjects section describes healthy males, but their BMI ranged from 21 to 32; the paper does not establish the finding specifically for lean subjects. (LLM, conf=0.82)
- Supportedcites [7] 7. Berne, C., J. Fagius, T. Pollare, and P. Hjemdahl. 1992. The sympathetic response to euglycaemic hyperinsulinaemia: evidence from microelectrode nerve recordings in healthy subjects. Diabetologia. 35:873–879. source
In the Discussion (page not available in our copy), the authors report that insulin increased muscle sympathetic activity at a high physiological concentration and suggest that this response helps maintain blood pressure despite insulin’s vasodilatory effects. The Abstract reports that blood pressure was not notably affected in the healthy subjects studied. This supports the proposed balance as a possible explanation, rather than an established mechanism. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [26] 26. Rowe, J. W., J. B. Young. K. L. Minaker, A. L. Stevens, J. Pallota, and L. Landsberg. 1981. Effects of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:219–225. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“During fructose infusion, plasma glucose concentrations remained stable, whereas plasma fructose concentrations rose from undetectable levels to 2.0±0.2 mmol/liter by the end of the first hour of infusion, and remained unchanged thereafter (Table I).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 78 claims and to verify the 5 references still open.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In our laboratory, the intraobserver and interobserver coefficients of variation of the mean in identifying bursts are < 6% and < 9%, respectively (14).”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“First, MS components such as visceral obesity, peripheral insulin resistance, and reactive hyperinsulinemia have been found to result in sympathetic hyperactivity.[5][6][7]”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lean subjects, sympathetic activation evoked by acute elevation of plasma insulin to high physiological concentrations does not raise blood pressure (12–14)”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“In lean healthy subjects, insulin-induced stimulation of muscle blood flow consistently is accompanied by a marked stimulation of sympathetic neural outflow to the same vascular bed (12-14).”
From Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. (1994) · cites this paper as [14]
In the citing paper
“Sympathetic activation has already been associated with many of the individual components of the MS, such as visceral obesity, 5 insulinemia, 6 EHT, [1][2][3][4] and type 2 diabetes.7”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Nonoxidative glucose disposal (pmol/kg per min) | - | 21±4 | 22±8 | - | 6±1t”
Reported 6 · recomputed 12
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results · p. 3
“had no effect on MSNA, calf blood flow, or calf vascular resistance”
§ Analytical methods · p. 3
“| Calf vascular resistance (Units) | 43.3±1.3 | 34.3±1.6* | 32.8±2.0* | 45.6±2.2 | 42.9±2.7* | 40.5±3.2* | 49.7±5.3 | 49.0±5.7t | 45.7±5.2* |”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Coated Charcoal Immunoassay of Insulin
HERBERT, V., LAU, K.-S., GOTTLIEB, C. W., & BLEICHER, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,968
Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves
Vallbo, A. B., Hagbarth, K. E., Torebjork, H. E., & Wallin, B. G. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.4.919 · Cited by 1,507
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.
Schuler, G., Hambrecht, R., Schlierf, G., Niebauer, J., Hauer, K., Neumann, J., Hoberg, E., Drinkmann, A., Bacher, F., & Grunze, M. (1992) · Circulation · doi:10.1161/01.cir.86.1.1 · Cited by 1,340
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981) · Diabetes · doi:10.2337/diab.30.3.219 · Cited by 1,143
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075
Hawk’s Physiological Chemistry
Prosky, L. (1966) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/49.2.477 · Cited by 1,047
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Parati, G., Casadei, R., Groppelli, A., Di Rienzo, M., & Mancia, G. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.647 · Cited by 899
Hawk's physiological chemistry
HAWK, P. B., & Oser, B. L. (1965) · Medical Entomology and Zoology · Cited by 871
Cited by
Items 201–300 of 323
Impaired response of cardiac autonomic nervous system to glucose load in severe obesity
Quilliot, D., Zannad, F. M., & Ziegler, O. (2005) · Metabolism · doi:10.1016/j.metabol.2005.03.002 · Cited by 17
“Previous studies using euglycemic hyperinsulinemic glucose clamp have demonstrated that hyperinsulinemia [24-27] affects the indicators of peripheral sympathetic activity (microelectrode nerve recordings, noradrenaline levels).”
MethodResultHoughton, A. R., Harrison, M., Perry, A. J., Evans, A. J., & Cowley, A. J. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0774 · Cited by 15
Shibasaki, S., Eguchi, K., Matsui, Y., Ishikawa, J., Hoshide, S., Ishikawa, S., Kabutoya, T., Pickering, T. G., Shimada, K., & Kario, K. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832a6d6a · Cited by 14
Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension
Chen, W., Leo, S., Weng, C., Yang, X., Wu, Y. F., & Tang, X. (2014) · Herz · doi:10.1007/s00059-014-4072-7 · Cited by 17
Haemodynamic actions of insulin
Tack, G. J. J., Lenders, J. W. M., Goldstein, D. S., Lutterman, J. A., Smits, P., & Thien, T. A. (1998) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199801000-00016 · Cited by 14
Kawaguchi, M., Koshimura, K., Sohmiya, M., Murakami, Y., Gonda, T., & Kato, Y. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450343 · Cited by 14
Trovati, M., Massucco, P., Mattiello, L., Cavalot, F. L., Mularoni, E., Hahn, A., & Anfossi, G. (1996) · Diabetologia · doi:10.1007/bf02658501 · Cited by 14
“In healthy subjects, euglycaemic infusion of insulin activates the SNS [10-16] without increasing blood pressure [11, 13, 15, 16].”
BackgroundInfluentialSkeletal muscle blood flow is not a determinant of insulin resistance in essential hypertension
Hunter, S. J., Harper, R., Ennis, C. N., Sheridan, B., Atkinson, A. B., & Bell, P. M. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715010-00007 · Cited by 14
Blackwood, S. J., Tischer, D., van de Ven, M. P. F., Pontén, M., Edman, S., Horwath, O., Apró, W., Röja, J., Ekblom, M., Moberg, M., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00148.2024 · Cited by 15
Simple Exercise Recovery Index for Sympathetic Overactivity Is Linked to Insulin Resistance
Yeckel, C. W., Gulanski, B., Zgorski, M., DZIURA, J., Parish, R., & Sherwin, R. S. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31818afa2f · Cited by 16
“Both compounds cause similar carbohydrate oxidation, but unlike glucose, fructose elicits neither a major insulin response nor a muscle sympathetic nerve response (50).”
BackgroundFan, X., Anderson, E. J., Copeland, P. M., Borba, C. P. C., Nguyen, D. D., Freudenreich, O., GOFF, D. C., & Henderson, D. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.006 · Cited by 13
Burke, S. L., Prior, L. J., Lukoshkova, E. V., Lim, K., Barzel, B., Davern, P. J., Armitage, J. A., & Head, G. A. (2013) · Chronobiology International · doi:10.3109/07420528.2013.784771 · Cited by 13
“Importantly, muscle sympathetic nerve activity and noradrenaline spillover to kidneys increase in response to peripheral insulin infusion or within 1 h of a high-fat meal (Cox et al., 1995; Vollenweider et al., 1993) and RSNA increases with central nervous system (CNS) administration of leptin (Prior et al.”
BackgroundDela, F., Stallknecht, B. M., & Biering‐Sørensen, F. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000444 · Cited by 13
“However, this view is opposed by the finding that similar glucose oxidation with hyperinsulinemia and that without do not elicit similar increases in blood flow [ 35 ].”
ResultScherrer, U. (1995) · Springer eBooks · doi:10.1007/978-3-642-79803-0_10 · Cited by 14
Self-citationKawaguchi, M., Koshimura, K., Murakami, Y., Tsumori, M., Gonda, T., & Kato, Y. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400341 · Cited by 14
Vascular Actions of Insulin in Health and Disease
Baron, A., & Steinberg, H. O. (1996) · Humana Press eBooks · doi:10.1007/978-1-4612-0231-8_7 · Cited by 13
Lambert, G. W., Patel, M., & Lambert, É. (2025) · Metabolites · doi:10.3390/metabo15050286 · Cited by 15
“Similarly, in response to carbohydrates, an elevation of MSNA is evident following glucose but not fructose infusion [50].”
Young, C. N., Deo, S. H., Kim, A., Horiuchi, M., Mikus, C. R., Uptergrove, G. M., Thyfault, J. P., & Fadel, P. J. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01174.2009 · Cited by 12
Isobe, Y., Nakatsumi, Y., Sugiyama, Y., Hamaoka, T., Murai, H., Takamura, M., Kaneko, S., Takata, S., & Takamura, T. (2019) · Internal Medicine · doi:10.2169/internalmedicine.3005-19 · Cited by 14
“Indeed, hyperinsulinemia can lead to increased sympathetic activity (37).”
BackgroundMeneilly, G. S., Battistini, B. J., & Floras, J. S. (2000) · Metabolism · doi:10.1016/s0026-0495(00)90330-5 · Cited by 13
PITT, M. S., & Hainsworth, R. (2004) · Clinical Autonomic Research · doi:10.1007/s10286-004-0198-7 · Cited by 12
“It is a vasodilator agent [9, 11, 35, 39] but it also potentates sympathetic activity [2, 5, 39, 40].”
BackgroundGreaney, J. L., Stanhewicz, A. E., & Kenney, W. L. (2019) · The Journal of Physiology · doi:10.1113/jp278237 · Cited by 12
“This finding was unexpected given that dyslipidaemia has been associated with aberrant regulation of sympathetic outflow to target vascular beds (Vollenweider et al. 1993; Lambert et al. 2013).”
BackgroundInsulin sensitivity in young women with vasovagal syncope
Ruiz, A., Calvar, C. E., Hermes, R., Rivadeneira, D., Bengolea, V., Chirife, R., TENTORI, M. C., & Gelpi, R. J. (2003) · American Heart Journal · doi:10.1016/s0002-8703(02)94707-1 · Cited by 11
ter Maaten, J. C., Serné, E. H., Bakker, S. J. L., van Eps, W. S., Donker, A. J. M., & Gans, R. O. B. (2001) · Metabolism · doi:10.1053/meta.2001.21681 · Cited by 10
Exercise and Protein Metabolism
Evans, W. J. (2015) · World review of nutrition and dietetics · doi:10.1159/000422347 · Cited by 10
Leyva, F. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1695 · Cited by 11
FUGMANN, A., Lind, L., Andersson, P.-E., Millgård, J., Hänni, A., Berne, C., & Lithell, H. (1998) · Acta Diabetologica · doi:10.1007/s005920050132 · Cited by 11
Cao, L., & Pilowsky, P. M. (2014) · Autonomic Neuroscience · doi:10.1016/j.autneu.2014.07.007 · Cited by 10
Osailan, A., Metsios, G. S., Rouse, P. C., Ntoumanis, N., Duda, J. L., Kitas, G. D., & Zanten, J. V. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0264-9 · Cited by 12
“Interestingly, insulin has been found to have a stimulatory effect on the sympathetic nervous system [63], and metabolic risk factors have been more strongly related to HRR2 than HRR1 in healthy participants.”
Habeeballah, H. H., Alsuhaymi, N., Stebbing, M. J., Jenkins, T. A., & Badoer, E. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2016.00672 · Cited by 10
“Similarly, central Frontiers in Physiology | www.frontiersin.org 6 January 2017 | Volume 7 | Article 672 administration of insulin has also been reported to have little effect acutely on blood pressure (Baron et al., 1993; Vollenweider et al., 1993; Rahmouni and Haynes, 2004).”
BackgroundFrontoni, S., Pellegrinotti, M., Bracaglia, D., Farrace, S., Caselli, A., Baroni, A., Angelis, C. D., Menzinger, G., & Gambardella, S. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00349.x · Cited by 9
ERLICH, Y., & Rosenthal, T. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00089-2 · Cited by 10
Hermann, T. S., Ihlemann, N., Domínguez, H., Rask‐Madsen, C., Køber, L., & Torp-Pedersen, C. T. (2004) · Endothelium · doi:10.1080/10623320490904098 · Cited by 10
Insights Into the Pathogenesis and Prevention of Coronary Artery Disease
O’Keefe, J. H., Lavie, C. J., & McCallister, B. D. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.1.69 · Cited by 9
SCOTT, E. M., Greenwood, J. P., Pernicova, I., Law, G. R., Gilbey, S. G., Kearney, M. T., & Mary, D. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.03.020 · Cited by 8
Endo, M. Y., Fujihara, C., Yamazaki, C., Kashima, H., Eguchi, K., Miura, A., Fukuoka, Y., & Fukuba, Y. (2014) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.1186/1880-6805-33-11 · Cited by 10
“[19] showed no change in muscle sympathetic nervous activity in the lower limbs during continuous venous infusion of fructose for two hours.”
BackgroundEffects of dexamethasone on the metabolic responses to mental stress in humans
Seematter, G., Battilana, P., & Tappy, L. (2002) · Clinical Physiology and Functional Imaging · doi:10.1046/j.1365-2281.2002.00409.x · Cited by 9
“Administration of insulin (Anderson et al., 1991; Vollenweider et al., 1993) or alcohol (Iwase et al., 1995) also enhances SNS activity.”
BackgroundInfluentialSelf-citationMuntzel, M. S., Morales, J., & Akinsefunmi, A. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01319-4 · Cited by 8
Trovati, M., Massucco, P., Mattiello, L., et al. (1995) · Diabetologia · doi:10.1007/s001250050374 · Cited by 8
Süfke, S., Djonlagić, H., & Kibbel, T. (2010) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-010-1150-3 · Cited by 8
“Außerdem wäre eher eine Wirkung auf die LF/ HF-Ratio in Richtung einer sympathischen Prädominanz zu erwarten gewesen [28,84].”
BackgroundKlemenc, M., Maver, J., Princi, T., Flander, P., & Golja, P. (2008) · European Journal of Applied Physiology · doi:10.1007/s00421-008-0835-2 · Cited by 9
Cardiovascular Effects of Sucrose in Experimental Animals and Humans
Nakayama, Y., Elliott, K. J., & Eguchi, S. (2025) · Hypertension · doi:10.1161/hypertensionaha.125.25720 · Cited by 11
Nitric oxide mediates the blood pressure response to mental stress in humans
Trueb, L., Lepori, M., Duplain, H., Scherrer, U., & Sartori, C. S. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13627 · Cited by 5
Self-citationDuanmu, Z., Scislo, T. J., & Dunbar, J. C. (1999) · Clinical and Experimental Hypertension · doi:10.3109/10641969909070847 · Cited by 6
Cardiovascular risks in obesity
Uchegbu, E., & Kopelman, P. G. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344056 · Cited by 6
Candesartan and Insulin Reduce Renal Sympathetic Nerve Activity in Hypertensive Type 1 Diabetic Rats
Takimoto, C., Kumagai, H., Osaka, M., Sakata, K., Onami, T., Kamayachi, T., Iigaya, K., Hayashi, K., Saruta, T., & Itoh, H. (2008) · Hypertension Research · doi:10.1291/hypres.31.1941 · Cited by 6
Vasodilator effect of insulin on the microcirculation of the rat cremaster muscle
Porter, J. P., Joshua, I. G., Kabithe, D., & Bokil, H. S. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00532-8 · Cited by 6
Diabetes and Metabolic Syndrome
Mahfoud, F., Ewen, S., & Böhm, M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-5223-1_23 · Cited by 5
LPIN1 is a new target gene for essential hypertension
Fujiwara, A., Ozawa, M., Sumida, K., Hirawa, N., Yatsu, K., Ichihara, N., Haze, T., Komiya, S., Ohki, Y., Kobayashi, Y., et al. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000003046 · Cited by 8
“However, hyperinsulinemia also causes vasodilatation in skeletal muscles [34].”
BackgroundFreemas, J. A., Greenshields, J. T., Baker, T. B., Carter, S. J., Johnson, B. D., & Schlader, Z. J. (2021) · Physiological Reports · doi:10.14814/phy2.14777 · Cited by 5
“our findings are consistent with previous observations that the infusion of fructose (Vollenweider et al., 1993) and consumption of a beverage sweetened with high- fructose corn syrup (Le et al.”
BackgroundResultInfluentialPlasma Metanephrines Are Associated With Glucose Metabolism in Patients With Essential Hypertension
Wang, W., Mu, L., Su, T., Ye, L., Jiang, Y., Jiang, L., & Zhou, W. (2015) · Medicine · doi:10.1097/md.0000000000001496 · Cited by 5
West, S., Smail, O., & Bond, B. (2019) · Microvascular Research · doi:10.1016/j.mvr.2019.103906 · Cited by 5
Celka, P., Vetter, R., Vesin, J.-M., Pruvot, E. J., & Scherrer, U. (1998) · Computers in Biology and Medicine · doi:10.1016/s0010-4825(98)00014-6 · Cited by 5
Self-citationFountaine, M. F. L., Cirnigliaro, C. M., Azarelo, F., Hobson, J. C., Tascione, O. F., Swonger, K. N., Dyson‐Hudson, T. A., & Bauman, W. A. (2017) · Experimental Physiology · doi:10.1113/ep086239 · Cited by 5
“In insulin-sensitive (IS) individuals, the vasodilatory effects of insulin are largely dependent on the release of nitric oxide from the endothelium and on the secondary withdrawal of sympathetic nervous system (SNS) vascular tone (Vollenweider et al. 1993; Sartori et al. 1999; Eringa et al. 2002; Tousoulis et al. 200…”
BackgroundInfluentialAutonomic dysfunction in polycystic ovary syndrome
Adams, Z. H., Simpson, L. L., Hart, E. C., & Lord, R. N. (2025) · Autonomic Neuroscience · doi:10.1016/j.autneu.2025.103357 · Cited by 4
Is There a Role for Renal Sympathetic Denervation in the Future Treatment of Resistant hypertension?
Mahfoud, F., Lenski, M., & Böhm, M. (2011) · Future Cardiology · doi:10.2217/fca.11.49 · Cited by 4
Effects of High Carbohydrate, High Fat and Protein Meal on Postprandial Thermogenesis in Young Women
노희경, 최인선, & 오승호 (2005) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2005.34.8.1202 · Cited by 4
Lymphocytic interstitial pneumonitis associated with autoimmune hepatitis.
Doshi, A. V., Desai, D., Bhaduri, A. S., & Udwadia, Z. F. (2001) · PubMed · Cited by 4
Cellular and Functional Effects of Insulin Based Therapies and Exercise on Endothelium
Luse, M. A., Heiston, E. M., Malin, S. K., & Isakson, B. E. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200721002735 · Cited by 4
Hypertension and Insulin Resistance
Natali, A., Taddei, S., & Ferrannini, E. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-3906-0_16 · Cited by 4
Metabolic control of the circulation: Implications for congestive heart failure
Delehanty, J. M., & Liang, C. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(05)80013-1 · Cited by 4
Wolfovitz, E., Pacák, K., Abassi, Z. A., Kopin, I. J., & Goldstein, D. S. (1995) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(94)00192-m · Cited by 5
Amin, S. N., Abdalgeleel, S. A., Al‐Gahtany, M., Shaltout, S. A., Gazzar, W. B. E., & Elberry, D. A. (2021) · Brain Sciences · doi:10.3390/brainsci11050644 · Cited by 3
“Human studies revealed a heterogenous sympathetic response with increased muscle sympathetic activity induced by insulin [76,77].”
BackgroundEffects of Cellulose and Pectin on Diet-induced Thermogenesis in Young Women
Oh, S.-H., Park, J.-J., Choi, I.-S., & Ro, H.-K. (2007) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2007.36.2.194 · Cited by 3
Role of sympathetic overactivity in the pathophysiology of the metabolic syndrome
Egan, B. M., & Julius, S. (2004) · Dialogues in Cardiovascular Medicine · Cited by 6
Neurovascular and hemodynamic responses to hyperinsulinemia in healthy postmenopausal women
Cardoso, C. G., Sakai, D., Pinto, L. G., Labes, E., de Gusmão, J. L., Abrahão, S. B., Tinucci, T., Mion, D., da Fonseca, Â. M., & Forjaz, C. L. M. (2007) · Maturitas · doi:10.1016/j.maturitas.2007.05.001 · Cited by 3
“Previous researches from us 4,5] and others [3,6–11] have reported that muscle ympathetic nerve activity, measured by microneuography, increases with hyperinsulinemia, while skin ympathetic activity does not change [11].”
BackgroundInfluentialProchnau, D., Figulla, H. R., & Surber, R. (2013) · Expert Review of Medical Devices · doi:10.1586/erd.13.1 · Cited by 3
Renale Denervierung: Atueller Stand und Perspektiven
Kara, K., Bruck, H., Kahlert, P., Plicht, B., Mahabadi, A. A., Konorza, T. F. M., & Erbel, R. (2012) · Herz · doi:10.1007/s00059-012-3689-7 · Cited by 4
Jéquier, E., & Tappy, L. (1997) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(97)00045-9 · Cited by 5
Self-citationSchwab, M., Bloch, J., Duplain, H., Sartori, C. S., & Scherrer, U. (2008) · PubMed · Cited by 4
Self-citationCorr, L. D., Douglas, A. J. M., Jenkins, E. J., Maier, L. E., Koep, J. L., Gibbons, T. D., Field, A., Anholm, J. D., Foster, K., Adams, Z. H., et al. (2025) · The Journal of Physiology · doi:10.1113/jp290241 · Cited by 2
Dysfonctions du système nerveux sympathique et de la signalisation catécholaminergique chez l’obèse
Lafontan, M. (2013) · Obésité · doi:10.1007/s11690-013-0409-2 · Cited by 2
Gallo‐Villegas, J., Aristizábal, D., Segura, Á., & Correa, M. (2008) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 5
Insulin and Insulin-Like Growth Factor I (IGF-I) Effects on Ca2+ and Nitric Oxide in Diabetes
Sowers, J. R. (1998) · Endocrine updates · doi:10.1007/978-1-4615-5569-8_8 · Cited by 2
VILLA, E., García‐Robles, R., & Romero, J. R. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00133-2 · Cited by 3
Schlaich, M. P. (2009) · Clinical Science · doi:10.1042/cs20090369 · Cited by 2
Divergent outcomes of fructose consumption on exercise capacity of rats: friend or foe
Sun, A., Huang, A., Kertowidjojo, E. C., Song, S. S., Hintze, T. H., & Sun, D. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00767.2016 · Cited by 2
“In this regard, human studies have provided evidence indicating that a bolus injection of glucose did (but fructose did not) initiate an insulin-dependent increase in calf blood flow (40).”
BackgroundGradel, A. K. J., Kildegaard, J., Porsgaard, T., Lykkesfeldt, J., & Refsgaard, H. H. F. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13574 · Cited by 2
Birkeland, K. I., Hanssen, K. F., Stranden, E., Falch, J. A., & Vaaler, S. (1995) · Blood Pressure · doi:10.3109/08037059509077574 · Cited by 2
Does acute hyperinsulinaemia change plasma adrenomedullin concentration in healthy men?
Nagai, Y., Yamashita, H., Takamura, T., & Kobayashi, K. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00231-3.x · Cited by 2
Galinier, M., Fourcade, J., Bovéda, S., Ley, N., Solera, S., Solera, M. L., Pirvu, O. M., MASSABUAU, P., Cabrol, P., Fauvel, J. M., et al. (1999) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.1999.tb00217.x · Cited by 2
Mechanisms of hypertension in hyperinsulinemic and insulin resistant fructose hypertensive rats
Verma, S. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0088178 · Cited by 3
Energy Metabolism and Sympathetic Activity in Patients with Insulin Resistance
Tappy, L., & Paquot, N. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-3906-0_12 · Cited by 2
Self-citationVerma, S., & McNeill, J. H. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1321-6_18 · Cited by 2
Brachmann, J., Schnupp, S., & Blüm, B. (2012) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2012.06.009 · Cited by 2
Glucose intolerance as the key risk factor for metabolic syndrome
Grassi, G. M. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13063
Breakfast skipping suppresses the vascular endothelial function of the brachial artery after lunch
Kashima, H., Seo, N., Endo, M. Y., Kanda, M., Miura, K., Kashima, N., Miura, A., & Fukuba, Y. (2024) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00681.2023 · Cited by 2
Obesity, sympathetic nervous system, and hypertension - are they connected?
Conrady, A. Ο. (2006) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2006-12-2-131-140 · Cited by 2
Doing nutrition research without knowing it: a Monsieur Jourdain’s travel through sugar metabolism
Tappy, L. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0699-z · Cited by 1
Self-citationGlucose uptake in skeletal muscle
Kolka, C. M. (2006) · UTAS Research Repository · doi:10.25959/23209628 · Cited by 1
Insulin regulation of muscle glucose metabolism: Role of pre‐receptorial mechanisms
Capaldo, B., & Saccà, L. (1995) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610110405 · Cited by 1
Mechanisms of fructose-induced hypertension
Tran, T. X. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0067067 · Cited by 1
Leyva, F., & Stevenson, J. C. (1999) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5181-2_22
Morgan, L. (2008) · Unitec Research Bank (Unitec Institute of Technology)
Physiological aspects of weight loss in obesity
Patel, K. (2011) · Nottingham ePrints (University of Nottingham)
Nutritional modulation of hepatic lipid metabolism in health and disease
Johnston, R. D. (2012) · Nottingham ePrints (University of Nottingham)
Endothelin-1 in the regulation of vascular function and glucose metabolism in insulin resistance
Shemyakin, A. S. (2010) · Figshare
Œdème lié à l'insuline : étude d'un cas clinique
Bensimon, S. (2013) · HAL
Metadata
- Authors
- Vollenweider, P., Tappy, L., Randin, D., Schneiter, P., Jéquier, E., Nicod, P., & Scherrer, U.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Venue
- Journal of Clinical Investigation
- Published
- 1993-07-01
- Volume
- 92
- Issue
- 1
- Pages
- 147-154
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC293552
- OpenAlex
- W2126021651
- Cited by
- 321
- References
- 55
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 8 · 2018: 3 · 2017: 11 · 2016: 12 · 2015: 7 · 2014: 9 · 2013: 12 · 2012: 15
- FWCI
- 47.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (28668)
- Nestec
- Topics
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- hyperinsulinemia, euglycemic clamp, muscle sympathetic nerve activity, skeletal muscle blood flow, carbohydrate metabolism, fructose infusion, glucose infusion, insulin, vasodilation, carbohydrate oxidation, energy expenditure
- MeSH terms
- Adult, Blood Glucose, Calorimetry, Catecholamines, Energy Metabolism, Fructose, Humans, Insulin, Muscles, Potassium, Regional Blood Flow, Sympathetic Nervous System, Vascular Resistance, Carbohydrate Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.